For medical device companies targeting the European market, your contract manufacturer's regulatory standing can be the difference between a smooth market entry and a costly delay.
In March 2026, SEACOMP's China facility successfully passed the EU MDR 2017/745 audit, conducted by ECM — one of the EU's designated Notified Bodies.
EU MDR Raises the Bar — By Design
The EU Medical Device Regulation 2017/745 is widely regarded as one of the most stringent medical device frameworks in the world. Compared to its predecessor (MDD), EU MDR demands significantly more rigorous clinical evidence, end-to-end traceability, post-market surveillance, and documentation requirements. Many manufacturers and their supply chains have found the transition genuinely difficult — years of preparation, internal audits, and process overhauls go into getting it right.
"This achievement would not have been possible without everyone's full cooperation, meticulous preparation, and consistent efforts."
— Robin Gu, Quality Manager
What This Means for Your Product
If you're developing medical technology for the EU market, you need a manufacturing partner whose processes can hold up to that scrutiny. Our EU MRD-compliant facility gives you:
- Verified traceability throughout the entire device lifecycle
- Rigorous documentation frameworks built for regulatory submissions
- Reduced compliance risk for your own EU market pathway
- A China-based facility with EU-recognized quality standards — a combination that remains rare in contract manufacturing
Ready to Bring Your Medical Device to Market?
Whether you're in early development or scaling toward launch, SEACOMP's EU MDR-compliant manufacturing capabilities are ready to support your path to the European market. Let's talk about what your product needs. Contact us today.